Abstract
Background The COVID-19 pandemic is affecting all Canadian families, with some impacted differently than others. Our study aims to: 1) determine the prevalence and transmission of SARS-CoV-2 infection among Canadian families, 2) identify predictors of infection susceptibility and severity of SARS-CoV-2 and 3) identify health and psychosocial impacts of the COVID-19 pandemic.
Methods This study builds upon the CHILD Cohort Study, an ongoing multi-ethnic general population prospective cohort consisting of 3454 Canadian families with children born in Vancouver, Edmonton, Manitoba, and Toronto between 2009-12. During the pandemic, 1462 CHILD households (5378 individuals) consented to participate in the CHILD COVID-19 Add-On Study involving: (1) brief biweekly surveys about COVID-19 symptoms and testing; (2) quarterly questionnaires assessing COVID-19 exposure, testing and vaccination status, physical and mental health, and pandemic-driven life changes; (3) in-home biological sampling kits to collect blood and stool. Mean ages were 9 years (range 0-17) for children and 43 years (range 18-85) for adults. Prevalence of SARS-CoV-2 infection will be estimated from survey data and confirmed through serology testing. We will combine these new data with a wealth of pre-pandemic CHILD data and use multivariate modelling and machine learning methods to identify risk and resilience factors for susceptibility and severity to the direct and indirect effects of the pandemic.
Interpretation Our short-term findings will inform key stakeholders and knowledge users to shape current and future pandemic responses. Additionally, this study provides a unique resource to study the long-term impacts of the pandemic as the CHILD Cohort Study continues.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by funding from the Canadian Institutes of Health Research and the Canadian COVID-19 Immunity Task Force [VR5-172658] and Research Manitoba [4494].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of the University of British Columbia (H20-02324), University of Alberta (Pro00102524), University of Manitoba (HS24250), The Hospital for Sick Children (1000071220) and McMaster University (1108).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Abbreviations
- ACE2
- Angiotensin-converting Enzyme 2
- BC
- British Columbia
- CANCOGEN
- Canadian COVID Genomics Network
- CANUE
- Canadian Urban Environmental Health Research Consortium
- CHILD
- Canadian Healthy Infant Longitudinal Development
- CINECA
- Common Infrastructure for National Cohorts in Europe, Canada, and Africa
- COVID-19
- Coronavirus disease 2019
- CRISIS
- CoRonavIruS Health Impact Survey
- DBS
- Dried Blood Spots
- ELISA
- Enzyme-linked Immunosorbent Assay
- IgG
- Immunoglobulin G
- NCC
- National Coordinating Centre
- NGOs
- Non-Governmental Organizations
- REDCap
- Research Electronic Data Capture
- SARS-CoV-2
- Severe Acute Respiratory Syndrome Coronavirus 2
- SNP
- Single Nucleotide Polymorphisms
- UNESCO
- United Nations Educational, Scientific and Cultural Organization
- UNICEF
- United Nations Children’ s Fund
- WHO
- World Health Organization